Replimune’s Post

🚨 Big news in cancer care! The new AI model CHIEF is setting new standards in cancer diagnostics, with up to 94% accuracy. This could reshape how we detect and treat cancer globally. #AIinHealthcare #CancerCare #HealthTech

Let’s talk about your upcoming global trial.

Our Public Webinar on Cancer Clinical Trials is now available to watch back: https://bit.ly/3Kdtib0 Share this link with patients, patient advocates, and anyone who might want to hear more about trials in an accessible and engaging way. #ClinicalTrials #PatientStories #CancerResearch #LungCancer

📆 If you missed our #ASH24 poster presentation, "A Pragmatic Approach for Quantifying Treatment Tolerability in Multiple Myeloma Clinical Practice Using Patient-Reported Outcomes (PROs)," no worries! 💻 As promised, you can now view the poster on our website: https://lnkd.in/eDfcGFgq 💡 Learn about how cancer care is evolving to focus on patient experience, including tolerability during treatment. Our research presents a methodology to quantify tolerability in myeloma using PROs collected in real-world clinical practice.   If you are interested and want to learn more about Carevive SMARTData®, send us a note through LinkedIn messaging. Aaron Galaznik Emelly Rusli Keri Collette Mordecai Kramer #ASH24 #HealthcareInnovation #TeamCarevive #PatientExperience #MultipleMyeloma #digitaloncology #cancer #cancercare #oncology #patientreportedoutcomes #oncologydata #clinicalinnovation #drugcommercialization #RWD #RWE #smartdata 

Early detection can save lives..by cancer early

This week, the Polaris team is busy with virtual interviews with clinicians serving lung cancer patients. Only in actively listening to clinicians can we really understand what their experiences are in care delivery, which is a critical step in identifying systematic gaps. #AssessingProviderExperience #IdentifyingCareDeliveryGaps #SometimesWeDressAlike

Lung cancer remains the leading cause of cancer deaths in Florida, with early diagnosis rates alarmingly low at just 25.3%. Early detection is vital—significantly improving survival rates—yet many at-risk individuals aren’t being screened. Irisaida Mendez’s story illustrates both the challenges and hope in this fight. After a devastating diagnosis, an experimental immunotherapy drug gave her a second chance, inspiring her to advocate for early detection. Healthcare providers and communities must prioritise access to screening, especially for high-risk groups. Together, we can improve outcomes and save lives. #LungCancerAwareness #EarlyDetection #HealthcareAdvocacy

On National Cancer Awareness Day, CNH Health News shines a light on the latest breakthroughs in cancer research. #NationalCancerAwarenessDay #CancerResearch #HealthNews #StayInformed #StayHealthy

Everyone deserves good healthcare, and no one deserves lung cancer. Help improve #healthequity by learning more about #lungcancer risk, detection and treatment.

The rapid diagnostic test we are developing for prostate cancer is a gamechanger. Tonight, our work was featured on ITV Wales News, with CEO Dave Taylor explaining the impact our groundbreaking test could have on men’s health and the NHS. Watch the report in full here: https://lnkd.in/ecUmCCuK #lateralflow #diagnostics #diagnostictest #prostatecancer #medtech #lateralflow